Literature DB >> 14564518

Water retention in the acute phase of Kawasaki disease: relationship between oedema and the development of coronary arterial lesions.

Hiroyuki Suzuki1, Takashi Takeuchi, Takaomi Minami, Shoichi Shibuta, Shigeru Uemura, Norishige Yoshikawa.   

Abstract

UNLABELLED: Despite intravenous immunoglobulin therapy, a certain percentage of patients with Kawasaki disease (KD) still develop coronary arterial lesions (CAL). In an effort to find new combined therapies to reduce the incidence of CAL, we focused on the oedema which can be an important sign of the increased vascular permeability in KD. A total of 127 patients with KD were included in the retrospective study. Serial weekly changes in serum sodium and albumin levels from the 1st to the 4th week of illness were examined. In addition, the maximum rate of increase in body weight from admission to the 14th day of illness was evaluated. Serum sodium levels (mEq/l) in only the 2nd week of illness were significantly lower in patients with CAL than in those without CAL (mean +/- SD, 135.5+/-4.5 versus 138.0+/-2.4, P<0.05). Serum albumin levels in all 4 weeks were significantly lower in patients with CAL than in those without CAL ( P<0.001). The maximum rate (%) of increase in body weight from admission to the 14th day of illness was significantly higher in patients with CAL than in those without CAL (ranges and median values, 0-12.3 (7.0) versus 0-10.3 (3.2), P<0.001).
CONCLUSION: these results suggest that water retention in the acute phase of Kawasaki disease may be a risk factor for CAL, and water intake of both infusion and oral intake should be kept to a minimum in order to avoid progressive oedema.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564518     DOI: 10.1007/s00431-003-1326-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.

Authors:  T Ohno; H Igarashi; K Inoue; K Akazawa; K Joho; T Hara
Journal:  Eur J Pediatr       Date:  2000-06       Impact factor: 3.183

2.  Hyponatremia in Kawasaki disease.

Authors:  R M Laxer; R E Petty
Journal:  Pediatrics       Date:  1982-10       Impact factor: 7.124

3.  Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.

Authors:  T Yoshioka; T Matsutani; S Iwagami; T Toyosaki-Maeda; T Yutsudo; Y Tsuruta; H Suzuki; S Uemura; T Takeuchi; M Koike; R Suzuki
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

4.  Vascular endothelial growth factor in acute Kawasaki disease.

Authors:  M Terai; K Yasukawa; S Narumoto; S Tateno; S Oana; Y Kohno
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

5.  [Hyponatremia and inflammation].

Authors:  M Ohta; S Ito
Journal:  Rinsho Byori       Date:  1999-05

6.  Detection of auto-antibodies against a 70 kDa protein derived from vascular smooth muscle cells in patients with Kawasaki disease.

Authors:  Hiroyuki Suzuki; Yasuteru Muragaki; Shigeru Uemura; Takashi Takeuchi; Takaomi Minami; Shoichi Shibuta; Akira Ohshima; Norishige Yoshikawa
Journal:  Eur J Pediatr       Date:  2002-04-18       Impact factor: 3.183

7.  Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease.

Authors:  Kumi Yasukawa; Masaru Terai; Stanford T Shulman; Tetsuya Toyozaki; Shigehiro Yajima; Yoichi Kohno; Anne H Rowley
Journal:  Circulation       Date:  2002-02-12       Impact factor: 29.690

8.  Intravenous gamma-globulin treatment in Kawasaki disease.

Authors:  K Harada
Journal:  Acta Paediatr Jpn       Date:  1991-12

9.  Acute heart failure and acute renal failure in Kawasaki disease.

Authors:  H Senzaki; M Suda; S Noma; H Kawaguchi; Y Sakakihara; T Hishi
Journal:  Acta Paediatr Jpn       Date:  1994-08

10.  Increased serum levels of vascular endothelial growth factor in Kawasaki disease.

Authors:  N Maeno; S Takei; K Masuda; H Akaike; K Matsuo; I Kitajima; I Maruyama; K Miyata
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

View more
  3 in total

1.  Serum sodium levels in patients with Kawasaki disease.

Authors:  H Muta; M Ishii; K Egami; S Hayasaka; Y Nakamura; H Yanagawa; T Matsuishi
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Predicting Intravenous Immunoglobulin Resistance Among North American Children Hospitalized With Kawasaki Disease.

Authors:  Jasdip Singh; Arthur Chang; Nicholas M Fusco; Mark Hicar
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

3.  Risk Factors for Coronary Artery Lesionsin Kawasaki Disease Independent of Antibiotic Use in Chinese Children.

Authors:  Sixian Lao; Tao Zhou; Ho-Chang Kuo; Guoping Zhong; Weiwei Zeng
Journal:  Front Public Health       Date:  2022-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.